Spravato, an esketamine nasal spray, offers rapid relief for treatment-resistant depression, providing hope and faster mood improvement when traditional treatments
December 4, 2025
No Comments
Blog & News
- Home
- healthcare-news
Treatment-resistant depression resists traditional treatments. Spravato (esketamine) at Aspire TMS Clinic offers a rapid, FDA-approved nasal spray therapy, providing new
November 30, 2025
No Comments
Spravato, a supervised nasal spray for treatment-resistant depression, offers fast relief by targeting brain receptors. Aspire TMS Clinic provides safe,
October 25, 2025
No Comments
Spravato, an esketamine nasal spray, offers rapid relief for treatment-resistant depression. Administered under clinical supervision at Aspire TMS Clinic, it
October 23, 2025
No Comments
